Nevro Corp (NVRO)
4.52
+0.16
(+3.67%)
USD |
NYSE |
Nov 22, 16:00
4.515
0.00 (0.00%)
After-Hours: 20:00
Nevro Revenue (TTM): 419.15M for Sept. 30, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
Date | Value |
---|---|
September 30, 2024 | 419.15M |
June 30, 2024 | 426.10M |
March 31, 2024 | 430.75M |
December 31, 2023 | 425.17M |
September 30, 2023 | 422.84M |
June 30, 2023 | 419.45M |
March 31, 2023 | 414.85M |
December 31, 2022 | 406.36M |
September 30, 2022 | 395.28M |
June 30, 2022 | 388.02M |
March 31, 2022 | 386.14M |
December 31, 2021 | 386.90M |
September 30, 2021 | 393.88M |
June 30, 2021 | 409.13M |
March 31, 2021 | 363.19M |
December 31, 2020 | 362.05M |
September 30, 2020 | 366.69M |
June 30, 2020 | 358.39M |
March 31, 2020 | 395.57M |
December 31, 2019 | 390.26M |
September 30, 2019 | 383.82M |
Date | Value |
---|---|
June 30, 2019 | 379.29M |
March 31, 2019 | 381.80M |
December 31, 2018 | 387.29M |
September 30, 2018 | 377.31M |
June 30, 2018 | 363.93M |
March 31, 2018 | 345.87M |
December 31, 2017 | 326.67M |
September 30, 2017 | 299.24M |
June 30, 2017 | 277.91M |
March 31, 2017 | 255.29M |
December 31, 2016 | 228.50M |
September 30, 2016 | 191.10M |
June 30, 2016 | 145.58M |
March 31, 2016 | 101.60M |
December 31, 2015 | 69.61M |
September 30, 2015 | 46.20M |
June 30, 2015 | 39.46M |
March 31, 2015 | 35.57M |
December 31, 2014 | 32.57M |
September 30, 2014 | 29.05M |
June 30, 2014 | 26.58M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
358.39M
Minimum
Jun 2020
430.75M
Maximum
Mar 2024
398.01M
Average
395.43M
Median
Revenue (TTM) Benchmarks
Inspire Medical Systems Inc | 755.59M |
Inari Medical Inc | 574.50M |
Stereotaxis Inc | 25.14M |
Electromed Inc | 57.06M |
Myomo Inc | 25.24M |